Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs WYETH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA WYETH GSK PHARMA/
WYETH
 
P/E (TTM) x 62.2 27.7 224.5% View Chart
P/BV x 18.9 11.3 167.7% View Chart
Dividend Yield % 1.6 10.9 15.2%  

Financials

 GSK PHARMA   WYETH
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
WYETH
Mar-14
GSK PHARMA/
WYETH
5-Yr Chart
Click to enlarge
High Rs1,6841,065 158.1%   
Low Rs1,231553 222.5%   
Sales per share (Unadj.) Rs191.9289.5 66.3%  
Earnings per share (Unadj.) Rs35.938.7 92.7%  
Cash flow per share (Unadj.) Rs39.839.9 99.6%  
Dividends per share (Unadj.) Rs32.00145.00 22.1%  
Avg Dividend yield %2.217.9 12.3%  
Book value per share (Unadj.) Rs102.9118.5 86.8%  
Shares outstanding (eoy) m169.4122.72 745.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.62.8 271.6%   
Avg P/E ratio x40.620.9 194.3%  
P/CF ratio (eoy) x36.720.3 180.8%  
Price / Book Value ratio x14.26.8 207.5%  
Dividend payout %89.2374.7 23.8%   
Avg Mkt Cap Rs m246,85818,381 1,343.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,950359 1,659.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,5176,577 494.4%  
Other income Rs m1,007347 289.8%   
Total revenues Rs m33,5246,925 484.1%   
Gross profit Rs m8,0331,023 785.1%  
Depreciation Rs m65827 2,402.0%   
Interest Rs m184 412.8%   
Profit before tax Rs m8,3641,339 624.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288460 497.7%   
Profit after tax Rs m6,076879 691.1%  
Gross profit margin %24.715.6 158.8%  
Effective tax rate %27.434.3 79.7%   
Net profit margin %18.713.4 139.8%  
BALANCE SHEET DATA
Current assets Rs m24,9433,964 629.2%   
Current liabilities Rs m13,2642,081 637.3%   
Net working cap to sales %35.928.6 125.5%  
Current ratio x1.91.9 98.7%  
Inventory Days Days9735 277.3%  
Debtors Days Days216278 77.8%  
Net fixed assets Rs m6,988878 796.0%   
Share capital Rs m1,694227 745.6%   
"Free" reserves Rs m15,7352,466 638.2%   
Net worth Rs m17,4302,693 647.2%   
Long term debt Rs m025 0.0%   
Total assets Rs m31,9304,842 659.5%  
Interest coverage x462.6306.0 151.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.01.4 75.0%   
Return on assets %19.118.2 104.6%  
Return on equity %34.932.6 106.8%  
Return on capital %48.149.4 97.3%  
Exports to sales %00.1 0.0%   
Imports to sales %48.134.7 138.6%   
Exports (fob) Rs mNA8 0.0%   
Imports (cif) Rs m15,6302,281 685.2%   
Fx inflow Rs m1,6228 21,309.9%   
Fx outflow Rs m15,6302,298 680.1%   
Net fx Rs m-14,008-2,291 611.5%   
CASH FLOW
From Operations Rs m4,8421,188 407.5%  
From Investments Rs m8,079287 2,816.2%  
From Financial Activity Rs m-15,433-4,296 359.3%  
Net Cashflow Rs m-2,512-2,821 89.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.7%  
Indian inst/Mut Fund % 11.6 18.4 63.0%  
FIIs % 2.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.9 51.1%  
Shareholders   114,663 25,706 446.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs WYETH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs WYETH Share Price Performance

Period GSK Pharma WYETH S&P BSE HEALTHCARE
1-Day 3.26% -2.27% 1.18%
1-Month -9.77% 18.58% -0.75%
1-Year 52.63% 69.59% 61.82%
3-Year CAGR 10.89% 15.36% 18.16%
5-Year CAGR 8.44% 8.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the WYETH share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of WYETH the stake stands at 51.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of WYETH.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of WYETH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.